Transcription of WHO Drug Information
{{id}} {{{paragraph}}}
WHO drug Information Vol. 31, No. 2, 2017 WHO drug Information Contents Medicines regulation Regulatory news 153 Regulating medicine manufacturers: 177 Pre-market assessment is an on-site inspection the only Assessment of generics in China; New fast- option? track pathway in India ; australian orphan drug programme; EU Priority medicines 158 Placebo and drug kits in clinical trial scheme; EU medical devices regulation design 179 Adverse events reporting Pharmacovigilance in Europe; Adverse events of illicit drugs in UK. Quality monitoring 180 Supply 162 Survey of the quality of selected GMP for compounded medicines; Reporting antiretroviral medicines circulating in of shortages in Canada; Dispensing five African countries categories in Switzerland 180 Antimicrobial resistance India national action plan; New investments in Safety news Canada; Tripartite alignment on requirements 166 Safety warnings for antibacterials Dulaglutide; Darbepoetin alfa ; Caspofungin 181 Collaboration ; Pneumococcal vaccine ; Pembrolizumab EU and African regulators meet; Report on ; Vemurafenib ; Denosumab; Gadolinium EMA FDA assessment pilot; Swiss A
153 WHO Drug Information Vol. 31, No. 2, 2017 Medicines regulation Regulating medicine manufacturers: is an on-site inspection the only option? The Australian approach to …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Australian Pallet Survey 2017 Report, Australian, Survey, Ratings for the Australian National Network, Global Risk Management Survey, Military Abbreviations WW1 to present, Technology Executive Committee, Overview of Biocide Regulations in OECD Member Countries, OECD, Guidance on use of rainwater tanks